WSO - March 2024 - 246

Volume 19 Number 3 March 2024
Contents
Editorial
Reperfusion therapy for stroke: From improving global access to thrombectomy beyond 24 hours
Hugh S Markus
Thanks to our reviewers
Thanks to our reviewers, and editorial board changes
Hugh Markus
Reviews
Global stroke statistics 2023: Availability of reperfusion services around the world
Joosup Kim, Muideen T Olaiya, Deidre A De Silva, Bo Norrving, Jackie Bosch, Diana A De Sousa, Hanne K Christensen, Anna Ranta, Geoffrey A Donnan,
Valery Feigin, Sheila Martins, Lee H Schwamm, David J Werring, George Howard, Mayowa Owolabi, Jeyaraj Pandian, Robert Mikulik,
Tharshanah Thayabaranathan and Dominique A Cadilhac
Remote ischemic conditioning for stroke: A critical systematic review
Harry Keevil, Bethan E Phillips and Timothy J England
Systematic Reviews
Is telestroke more effective than conventional treatment for acute ischemic stroke? A systematic review and
meta-analysis of patient outcomes and thrombolysis rates
Ahmed Mohamed, Salah Elsherif, Brittney Legere, Nida Fatima, Ashfaq Shuaib and Maher Saqqur
Magnetic resonance imaging for diagnostic workup of embolic stroke of undetermined source: A systematic review
Natallia Khenkina, Alberto Aimo, Iacopo Fabiani, Pier Giorgio Masci, Dimitrios Sagris, Steven E Williams, George Mavraganis, Hui-Sheng Chen, Max Wintermark,
Patrik Michel, George Ntaios and Georgios Georgiopoulos
Research
Endovascular treatment for acute ischemic stroke beyond the 24-h time window: Selection by target mismatch profile
Trung Quoc Nguyen, Mai Hoang Tran, Hai Ngoc Phung, Khang Vinh Nguyen, Hang T Minh Tran, Silke Walter, Dinh C Bao Hoang, Binh Nguyen Pham,
Anh Le Tuan Truong, Vu Thanh Tran, Thanh N Nguyen, An Le Pham and Huy-Thang Nguyen
Iatrogenic cerebral amyloid angiopathy: A multinational case series and individual patient data analysis of the literature
Slaven Pikija, Janja Pretnar-Oblak, Senta Frol, Branko Malojcic, Thomas Gattringer, Kinga Rak-Frattner, Dimitre Staykov, Andrea Salmaggi, Riccardo Milani,
Jozef Magdic, Sarah Iglseder, Eugen Trinka, Theo Kraus, Andreea Toma, Jacopo C. DiFrancesco, Payam Tabaee Damavandi, Natalia Fabin, Anna Bersano,
Patricia de la Riva Juez, Ines Albajar Gomez, Benedetta Storti and Simon Fandler-Höfler
Safety and efficacy of tenecteplase versus alteplase in stroke patients with carotid tandem lesions: Results from the AcT trial 322
Fouzi Bala, Mohammed Almekhlafi, Nishita Singh, Ibrahim Alhabli, Ayoola Ademola, Shelagh B Coutts, Yan Deschaintre, Houman Khosravani, Ramana Appireddy,
Francois Moreau, Stephen Phillips, Gord Gubitz, Aleksander Tkach, Luciana Catanese, Dar Dowlatshahi, George Medvedev, Jennifer Mandzia, Aleksandra Pikula,
Jay Shankar, Heather Williams, Thalia S Field, Alejandro Manosalva, Muzaffar Siddiqui, Atif Zafar, Oje Imoukhoude, Gary Hunter, Faysal Benali, MacKenzie Horn,
Michael D Hill, Michel Shamy, Tolulope T Sajobi, Brian H Buck, Richard H Swartz, Bijoy K Menon and Alexandre Y Poppe
Domain-specific cognitive impairment 6 months after stroke: The value of early cognitive screening
Elise T Milosevich, Margaret J Moore, Sarah T Pendlebury and Nele Demeyere
Changes in anticoagulation practice in subjects admitted with stroke associated with atrial fibrillation, following
introduction of direct oral anticoagulants over 2013-2021
Joseph Harbison, Joan McCormack, Olga Brych, Ronan Collins, Niamh O'Connell, Mary Randles, Cormac Kennedy, Peter J Kelly and Tim Cassidy
Association of multimorbidity with mortality after stroke stratified by age, severity, etiology, and prior disability
Matthew B Downer, Ramon Luengo-Fernandez, Lucy E Binney, Sergei Gutnikov, Louise E Silver, Aubretia McColl and Peter M Rothwell;
On Behalf of the Oxford Vascular Study
348
331
342
314
293
271
248
251
253
280
305

WSO - March 2024

Table of Contents for the Digital Edition of WSO - March 2024

Contents
WSO - March 2024 - Cover1
WSO - March 2024 - Cover2
WSO - March 2024 - 245
WSO - March 2024 - Contents
WSO - March 2024 - 247
WSO - March 2024 - 248
WSO - March 2024 - 249
WSO - March 2024 - 250
WSO - March 2024 - 251
WSO - March 2024 - 252
WSO - March 2024 - 253
WSO - March 2024 - 254
WSO - March 2024 - 255
WSO - March 2024 - 256
WSO - March 2024 - 257
WSO - March 2024 - 258
WSO - March 2024 - 259
WSO - March 2024 - 260
WSO - March 2024 - 261
WSO - March 2024 - 262
WSO - March 2024 - 263
WSO - March 2024 - 264
WSO - March 2024 - 265
WSO - March 2024 - 266
WSO - March 2024 - 267
WSO - March 2024 - 268
WSO - March 2024 - 269
WSO - March 2024 - 270
WSO - March 2024 - 271
WSO - March 2024 - 272
WSO - March 2024 - 273
WSO - March 2024 - 274
WSO - March 2024 - 275
WSO - March 2024 - 276
WSO - March 2024 - 277
WSO - March 2024 - 278
WSO - March 2024 - 279
WSO - March 2024 - 280
WSO - March 2024 - 281
WSO - March 2024 - 282
WSO - March 2024 - 283
WSO - March 2024 - 284
WSO - March 2024 - 285
WSO - March 2024 - 286
WSO - March 2024 - 287
WSO - March 2024 - 288
WSO - March 2024 - 289
WSO - March 2024 - 290
WSO - March 2024 - 291
WSO - March 2024 - 292
WSO - March 2024 - 293
WSO - March 2024 - 294
WSO - March 2024 - 295
WSO - March 2024 - 296
WSO - March 2024 - 297
WSO - March 2024 - 298
WSO - March 2024 - 299
WSO - March 2024 - 300
WSO - March 2024 - 301
WSO - March 2024 - 302
WSO - March 2024 - 303
WSO - March 2024 - 304
WSO - March 2024 - 305
WSO - March 2024 - 306
WSO - March 2024 - 307
WSO - March 2024 - 308
WSO - March 2024 - 309
WSO - March 2024 - 310
WSO - March 2024 - 311
WSO - March 2024 - 312
WSO - March 2024 - 313
WSO - March 2024 - 314
WSO - March 2024 - 315
WSO - March 2024 - 316
WSO - March 2024 - 317
WSO - March 2024 - 318
WSO - March 2024 - 319
WSO - March 2024 - 320
WSO - March 2024 - 321
WSO - March 2024 - 322
WSO - March 2024 - 323
WSO - March 2024 - 324
WSO - March 2024 - 325
WSO - March 2024 - 326
WSO - March 2024 - 327
WSO - March 2024 - 328
WSO - March 2024 - 329
WSO - March 2024 - 330
WSO - March 2024 - 331
WSO - March 2024 - 332
WSO - March 2024 - 333
WSO - March 2024 - 334
WSO - March 2024 - 335
WSO - March 2024 - 336
WSO - March 2024 - 337
WSO - March 2024 - 338
WSO - March 2024 - 339
WSO - March 2024 - 340
WSO - March 2024 - 341
WSO - March 2024 - 342
WSO - March 2024 - 343
WSO - March 2024 - 344
WSO - March 2024 - 345
WSO - March 2024 - 346
WSO - March 2024 - 347
WSO - March 2024 - 348
WSO - March 2024 - 349
WSO - March 2024 - 350
WSO - March 2024 - 351
WSO - March 2024 - 352
WSO - March 2024 - 353
WSO - March 2024 - 354
WSO - March 2024 - 355
WSO - March 2024 - 356
WSO - March 2024 - 357
WSO - March 2024 - 358
WSO - March 2024 - 359
WSO - March 2024 - 360
WSO - March 2024 - 361
WSO - March 2024 - 362
WSO - March 2024 - 363
WSO - March 2024 - 364
WSO - March 2024 - 365
WSO - March 2024 - 366
WSO - March 2024 - 367
WSO - March 2024 - 368
WSO - March 2024 - 369
WSO - March 2024 - 370
WSO - March 2024 - 371
WSO - March 2024 - 372
WSO - March 2024 - Cover3
WSO - March 2024 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com